… for the company. Johnson & Johnson faces relatively few ..... entire spectrum of Johnson & Johnson 's products should ..... s drug division. Johnson & Johnson carries one of the ..... equity portion of the Synthes acquisition, which …
By Trefis : Johnson & Johnson ( JNJ ) recently released its Q1 2013 financial results. Based ..... diagnostics segment saw a significant jump in revenues due to Synthes acquisition. However, it was noteworthy to see growth in cardiovascular …
… First Quarter 2013 Results On April 16, Johnson & Johnson ( JNJ ) reported 2013 first quarter results ..... quarter 2012. Sales include the impact of Synthes , net of divestiture of DePuy trauma ..... transaction cost related to the acquisition of Synthes , Inc.. Excluding the impact of this …
… this kind of growth. Johnson & Johnson posted an impressive ..... weak consumer base, Johnson & Johnson is still set for more growth. The news Johnson & Johnson saw a large boost ..... the acquisition of Synthes , a Swiss medical …
… medical and consumer products firm Johnson & Johnson ( JNJ ) reported solid fourth ..... for several special items. Johnson & Johnson 's international expansion ..... 6.8%. The acquisition of Synthes was the big needle-mover in …
By Stephen Simpson : With the Synthes acquisition done and Zytiga on the market, I don't think Johnson & Johnson ( JNJ ) investors should expect too much additional flash in 2013. That may not be such a bad thing, though, as this is a pretty …
More on Johnson & Johnson ( JNJ ) Q4 : net profit excluding special items +7.9% to $3 ..... associated with DePuy's recalled artificial hip. Acquisition of Synthes contributes 5.6% to sales growth. Domestic revenues +6.8 …
… inflection point for Johnson & Johnson , and we see the ..... device side, the Synthes acquisition not ..... from the recent Synthes acquisition, Johnson & Johnson posted 4% year ..... period, with the Synthes acquisition providing …
… Broens : Shares of Johnson & Johnson ( JNJ ) rose almost ..... Third Quarter Results Johnson & Johnson reported third quarter ..... the acquisition of Synthes which added 5.8 ..... earnings attributable to Johnson & Johnson fell 7.3% to …
… Valuentum : Dividend growth gem Johnson & Johnson ( JNJ ) posted strong results ..... calculate the intrinsic value of Johnson & Johnson via an extensive DCF process ..... billion. The acquisition of Synthes materially boosted medical device …